Post-marketing safety of pentosan polysulfate sodium: a 21-year pharmacovigilance analysis of the FAERS database
ObjectiveTo characterize the post-marketing safety profile of pentosan polysulfate sodium (PPS) using the FDA Adverse Event Reporting System (FAERS) database.MethodsThis pharmacovigilance study analyzed FAERS data spanning from the first quarter of 2004 to the first quarter of 2025. Disproportionali...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2026-01-01
|
| シリーズ: | Frontiers in Medicine |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1725094/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|